Summit Medical Group MD Anderson Cancer Center Appoints Dr. William T. DeRosa as Chief of Oncology

Share Article

In the newly established position, Dr. DeRosa will advance the vision of Summit Medical Group MD Anderson Cancer Center, helping to deliver an integrated approach to world-class cancer care.

William T. DeRosa, DO, FACP is new chief of oncology services at Summit Medical Group MD Anderson Cancer Center.

I look forward to working with the expert physicians and extremely talented professionals at Summit Medical Group MD Anderson Cancer Center as we strive to transform how healthcare and cancer treatment is delivered to our patients.

Summit Medical Group MD Anderson Cancer Center is pleased to announce that William T. DeRosa, DO, FACP, has been named its first chief of oncology services. Creating this position and appointing Dr. DeRosa to carry out the mission to advance and integrate quality cancer care is further example of the group’s commitment to patients in northern New Jersey and the New York metropolitan area.

Dr. DeRosa will remain in clinical practice part-time and also will serve on the Summit Medical Group Clinical Council. Recognized by colleagues and patients for high-quality and compassionate care, Dr. DeRosa has consistently ranked among “Best Doctors in America” by Best Doctors Inc. since 2003. Among his responsibilities are ensuring continuous improvement in patient care and safety, smooth business operations, flawless regulatory compliance, positive clinical outcomes and implementation of value-based care. Dr. DeRosa is also charged with overseeing the hiring, performance and mentoring of physicians in the oncology service and guiding clinical research teams to expand patient access to clinical trials.

“Dr. DeRosa’s experience and expertise in the field of medical oncology/hematology, as well as his commitment to compassionate care, is exactly in line with our patient-first philosophy,” said Jeffrey Le Benger, MD, chairman and CEO, Summit Medical Group. “I’m confident that Dr. DeRosa is the right candidate to carry out our mission to bring a multidisciplinary approach to treating cancer patients.”

“To be the first named oncology chief at Summit Medical Group is a great responsibility, and I am honored to take on this crucial role,” said Dr. DeRosa. “I look forward to working with the expert physicians and extremely talented professionals at Summit Medical Group MD Anderson Cancer Center as we strive to transform how healthcare and cancer treatment is delivered to our patients.”

Margaret Row, M.D., vice president, operations, MD Anderson Cancer Network, added: “Dr. DeRosa is an excellent choice to head a high-caliber leadership team and growing cancer program. His leadership will be extremely valuable as we continue to strengthen our collaboration with Summit Medical Group and work together to deliver innovative care to patients in the region.”

Dr. DeRosa attended the Kirksville College of Osteopathic Medicine in Kirksville, Missouri, completed his residency at Morristown Medical Center in Morristown, New Jersey, and was fellowship trained in hematology and oncology at Yale University School of Medicine in New Haven, Connecticut. He is board certified in internal medicine and medical oncology/hematology and is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians.

Summit Medical Group MD Anderson, which provides medical oncology, surgical oncology, infusion and diagnostic imaging, is already in place at Summit Medical Group’s flagship campus at 1 Diamond Hill Road in Berkeley Heights, New Jersey. Plans are also underway to build a state-of-the-art 130,000-square-foot building adjacent to Summit Medical Group’s new facility at 140 Park Avenue in Florham Park, New Jersey, with future services to include radiation oncology. Groundbreaking is expected at the new site this fall.

About Summit Medical Group MD Anderson Cancer Center
With a special emphasis on continuity of care, the Summit Medical Group MD Anderson Cancer Center was formed in 2016 through a partnership between Summit Medical Group (SMG) and MD Anderson Cancer Center to provide fully integrated, multidisciplinary cancer care for patients in northern New Jersey and the tristate area. An extension of MD Anderson Cancer Center at Cooper in Camden, New Jersey, Summit Medical Group MD Anderson Cancer Center is clinically integrated with MD Anderson Cancer Center in Houston, Texas. MD Anderson Cancer Center at Cooper joined MD Anderson Cancer Network®, a program of MD Anderson Cancer Center, in 2013. Summit Medical Group is one of four partner members of the network and contributes to MD Anderson’s mission to end cancer. For more information, visit http://www.summitmedicalgroup.com/service/Oncology-Center/.

About MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world’s most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world. Last year, more than 135,000 individuals came to MD Anderson for not only the largest clinical trials program in the world, but also for its signature multidisciplinary care. MD Anderson in Houston employs almost 21,000 cancer fighters, including nearly 1,700 physicians and scientists.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maureen Bennett
Visit website